Functional characterization of the recombinant human C1 inhibitor serpin domain: Insights into heparin binding

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4982-4989

  Rossi, Véronique ^a   Bally, Isabelle ^a   Ancelet, Sarah ^a   Xu, Yuanyuan ^c   Frémeaux Bacchi, Véronique ^b   Vivès, Romain R ^a   Sadir, Rabia ^a   Thielens, Nicole ^a   Arlaud, Gérard J ^a  

^a CNRS   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; HEPARIN; OLIGOMER; OLIGOSACCHARIDE; PROTEINASE; RECOMBINANT PROTEIN; SERINE PROTEINASE; COMPLEMENT COMPONENT C1S; SERINE PROTEINASE INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; BINDING AFFINITY; BINDING COMPETITION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG DETERMINATION; ENZYME ACTIVITY; HUMAN; INSECT CELL; MOLECULAR INTERACTION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECOMBINANT PLASMID; SURFACE PLASMON RESONANCE; THERMOSTABILITY; VIRAL GENE THERAPY; VIRUS RECOMBINANT; ANIMAL; ARMYWORM; CHEMISTRY; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR WEIGHT; MOTH; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SITE DIRECTED MUTAGENESIS; SWINE;

ANIMALS; BACULOVIRIDAE; BINDING, COMPETITIVE; CARBOHYDRATES; COMPLEMENT C1; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C1S; HEPARIN; HUMANS; MOLECULAR WEIGHT; MOTHS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SERPINS; SPODOPTERA; SWINE;

EID: 77954467020     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902016     Document Type: Article

References (38)

1. 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma. FEBS Lett. 97: 111-115.
2. Rossi, V., S. Cseh, I. Bally, N. M. Thielens, J. C. Jensenius, and G. J. Arlaud. 2001. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J. Biol. Chem. 276: 40880-40887.
3. Davis, A. E., 3rd, P. Mejia, and F. Lu. 2008. Biological activities of C1 inhibitor. Mol. Immunol. 45: 4057-4063.
4. Ambrus, G., P. Gál, M. Kojima, K. Szilágyi, J. Balczer, J. Antal, L. Gráf, A. Laich, B. E. Moffatt, W. Schwaeble, et al. 2003. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J. Immunol. 170: 1374-1382.
5. Schapira, M., C. F. Scott, and R. W. Colman. 1982. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J. Clin. Invest. 69: 462-468.
6. Pixley, R. A., M. Schapira, and R. W. Colman. 1985. The regulation of human factor XIIa by plasma proteinase inhibitors. J. Biol. Chem. 260: 1723-1729.
7. Wuillemin, W. A., M. Minnema, J. C. Meijers, D. Roem, A. J. Eerenberg, J. H. Nuijens, H. ten Cate, and C. E. Hack. 1995. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. Blood 85: 1517-1526.
8. Ligoudistianou, C., Y. Xu, G. Garnier, A. Circolo, and J. E. Volanakis. 2005. A novel human complement-related protein, C1r-like protease (C1r-LP), specifi- cally cleaves pro-C1s. Biochem. J. 387: 165-173.
9. Davis, A. E., 3rd, S. Cai, and D. Liu. 2007. C1 inhibitor: biologic activities that are independent of protease inhibition. Immunobiology 212: 313-323.
10. Bock, S. C., K. Skriver, E. Nielsen, H.-C. Thøgersen, B. Wiman, V. H. Donaldson, R. L. Eddy, J. Marrinan, E. Radziejewska, R. Huber, et al. 1986. Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry 25: 4292-4301.
11. Coutinho, M., K. S. Aulak, and A. E. Davis, 3rd. 1994. Functional analysis of the serpin domain of C1 inhibitor. J. Immunol. 153: 3648-3654.
12. Bos, I. G., Y. T. Lubbers, D. Roem, J. P. Abrahams, C. E. Hack, and E. Eldering. 2003. The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant. J. Biol. Chem. 278: 29463-29470.
13. Salvesen, G. S., J. J. Catanese, L. F. Kress, and J. Travis. 1985. Primary structure of the reactive site of human C1-inhibitor. J. Biol. Chem. 260: 2432-2436.
14. Wuillemin, W. A., H. te Velthuis, Y. T. Lubbers, C. P. de Ruig, E. Eldering, and C. E. Hack. 1997. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J. Immunol. 159: 1953-1960.
15. Eldering, E., J. H. Nuijens, and C. E. Hack. 1988. Expression of functional human C1 inhibitor in COS cells. J. Biol. Chem. 263: 11776-11779.
16. Wolff, M. W., F. Zhang, J. J. Roberg, E. E. Caldwell, P. R. Kaul, J. N. Serrahn, D. W. Murhammer, R. J. Linhardt, and J. M. Weiler. 2001. Expression of C1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization. Protein Expr. Purif. 22: 414-421.
17. Bos, I. G. A., E. C. de Bruin, Y. A. Karuntu, P. W. Modderman, E. Eldering, and C. E. Hack. 2003. Recombinant human C1-inhibitor produced in Pichia pastoris has the same inhibitory capacity as plasma C1-inhibitor. Biochim. Biophys. Acta 1648: 75-83.
18. Lamark, T., M. Ingebrigtsen, C. Bjørnstad, T. Melkko, T. E. Mollnes, and E. W. Nielsen. 2001. Expression of active human C1 inhibitor serpin domain in Escherichia coli. Protein Expr. Purif. 22: 349-358.
19. Beinrohr, L., V. Harmat, J. Dobó, Z. Lörincz, P. Gál, and P. Závodszky. 2007. C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. J. Biol. Chem. 282: 21100-21109.
20. Arlaud, G. J., R. B. Sim, A.-M. Duplaa, and M. G. Colomb. 1979. Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents. Mol. Immunol. 16: 445-450.
21. Arlaud, G. J., and N. M. Thielens. 1993. Human complement serine proteases C1r and C1s and their proenzymes. Methods Enzymol. 223: 61-82.
22. Bally, I., V. Rossi, N. M. Thielens, C. Gaboriaud, and G. J. Arlaud. 2005. Functional role of the linker between the complement control protein modules of complement protease C1s. J. Immunol. 175: 4536-4542.
23. Rossi, V., I. Bally, N. M. Thielens, A. F. Esser, and G. J. Arlaud. 1998. Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. J. Biol. Chem. 273: 1232-1239.
24. Thielens, N. M., C. A. Aude, M. B. Lacroix, J. Gagnon, and G. J. Arlaud. 1990. Ca2+ binding properties and Ca2(+)-dependent interactions of the isolated NH2-terminal alpha fragments of human complement proteases C1-r and C1-s. J. Biol. Chem. 265: 14469-14475.
25. Pétillot, Y., P. Thibault, N. M. Thielens, V. Rossi, M. Lacroix, B. Coddeville, G. Spik, V. N. Schumaker, J. Gagnon, and G. J. Arlaud. 1995. Analysis of the N-linked oligosaccharides of human C1s using electrospray ionisation mass spectrometry. FEBS Lett. 358: 323-328.
26. Harpel, P. C. 1976. C1 inactivator. Methods Enzymol. 45: 751-750.
27. Gill, S. C., and P. H. von Hippel. 1989. Calculation of protein extinction co-efficients from amino acid sequence data. Anal. Biochem. 182: 319-326.
28. Thielens, N. M., S. Cseh, S. Thiel, T. Vorup-Jensen, V. Rossi, J. C. Jensenius, and G. J. Arlaud. 2001. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J. Immunol. 166: 5068-5077.
29. King, L. A., and R. D. Possee. 1992. The Baculovirus Expression System: A Laboratory Guide. Chapman and Hall, Ltd, London.
30. Nagase, H., and G. Salvesen. 1989. Inhibition of proteolytic enzymes. In Proteolytic Enzymes, a Practical Approach. R. J. Beynon, and J. S. Bond, eds. IRL Press, Oxford, U.K., p. 144.
31. Tacnet-Delorme, P., S. Chevallier, and G. J. Arlaud. 2001. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions. J. Immunol. 167: 6374-6381.
32. Vivès, R. R., R. Sadir, A. Imberty, A. Rencurosi, and H. Lortat-Jacob. 2002. A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41: 14779-14789.
33. Attali, C., C. Frolet, C. Durmort, J. Offant, T. Vernet, and A.-M. Di Guilmi. 2008. Streptococcus pneumoniae choline-binding protein E interaction with plasminogen/plasmin stimulates migration across the extracellular matrix. Infect. Immun. 76: 466-476.
34. Rossi, V., C. Gaboriaud, M. Lacroix, J. Ulrich, J. C. Fontecilla-Camps, J. Gagnon, and G. J. Arlaud. 1995. Structure of the catalytic region of human complement protease C1s: study by chemical cross-linking and three-dimensional homology modeling. Biochemistry 34: 7311-7321.
35. Caldwell, E. E., A. M. Andreasen, M. A. Blietz, J. N. Serrahn, V. VanderNoot, Y. Park, G. Yu, R. J. Linhardt, and J. M. Weiler. 1999. Heparin binding and augmentation of C1 inhibitor activity. Arch. Biochem. Biophys. 361: 215-222.
36. Medved, L. V., T. F. Busby, and K. C. Ingham. 1989. Calorimetric investigation of the domain structure of human complement Cl-s: reversible unfolding of the short consensus repeat units. Biochemistry 28: 5408-5414.
37. Ziccardi, R. J. 1982. A new role for C1-inhibitor in homeostasis: control of activation of the first complement of human complement. J. Immunol. 128: 2505-2508.
38. Vivès, R. R., E. Crublet, J. P. Andrieu, J. Gagnon, P. Rousselle, and H. Lortat-Jacob. 2004. A novel strategy for defining critical amino acid residues involved in protein/glycosaminoglycan interactions. J. Biol. Chem. 279: 54327-54333.